Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Clinical Study of the Hybrid APC Therapy in Early Central Lung Neoplasms

NCT03537378 is registered in ClinicalTrials.gov with Jiayuan Sun as lead sponsor.

NCT NCT03537378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03537378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Clinical Study of the Hybrid APC Therapy in Early Central Lung Neoplasms
Lead sponsor
Jiayuan Sun
Phase
Not applicable
Overall status
Completed
Start date
December 26, 2018
Completion date
December 30, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms